Jeremy is the Vice President of Global Strategy and Analytics at Edwards Lifesciences supporting the Transcatheter Heart Valves (THV) business unit. In this position, Jeremy leads the development and implementation of the business unit strategic planning, portfolio strategy, and advanced analytics focused on improving the treatment of patients suffering from aortic heart valve disease globally. Over the past 12 years, he has held various leadership positions within Edwards Lifesciences on the commercial side of the organization, in both the Surgical and THV business units. Prior to joining Edwards in 2012, Jeremy worked at Phenomenex (a Danaher Company) with both sales and marketing responsibilities that catered to the pharmaceutical and biopharmaceutical industry.
Jeremy holds an undergraduate degree in Biology from the University of San Diego and a Master of Business Administration from Concordia University Irvine.